Jun 5 |
The 3 Best Biotech Stocks to Buy in June 2024
|
Jun 5 |
Intellia Therapeutics Presents Promising In Vivo CRISPR Results
|
Jun 4 |
Intellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data
|
Jun 4 |
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
|
Jun 3 |
Is Intellia Therapeutics, Inc. (NASDAQ:NTLA) the Most Promising Gene Therapy Stock to Buy Now?
|
Jun 3 |
Update: Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate
|
Jun 3 |
Intellia rallies on Phase 1 data for CRISPR-based HAE therapy
|
Jun 2 |
Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
|
May 31 |
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
|
May 28 |
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
|